Skip to main content

Table 1 The clinic- pathological features of patients with bone tumors

From: Evaluation of the expression pattern and diagnostic value of PPARγ in malignant and benign primary bone tumors

  

Malignant bone tumor

Benign bone tumor

Demographic features

Groups

Osteosarcoma (N = 30)

Ewing Sarcoma (N = 30)

GCT (N = 30)

Age

30

11(36.6%)

20(66.7%)

16(53.3%)

30

19(63.3%)

10(33.3%)

14(46.7%)

Gender

Male

16(53.3%)

12(40%)

17(56.7%)

Female 

14(46.7%)

18(60%)

13(43.3%)

Tumor size (cm)

10  

16(53.3%)

18(60%)

26(86.7%)

10

14(46.7%)

12(40%)

4(13.3%)

Tumor grade

Low (grade I/II)

11(36.7%)

10(33.3%)

30(100%)

High (grade III)

19(63.3%)

20(66.7%)

0(0%)

History of particular disease

Positive

7(23.3%)

4(13.3%)

4(13.3%)

Negative

23(76.7%)

26(86.7%)

26(86.7%)

Chemotherapy

Positive

17(56.7%)

17(56.7%)

0

Negative

13(43.3%)

13(43.3%)

30(100%)

Metastasis

Yes

9(30%)

9(30%)

0

No

21(70%)

21(70%)

30(100%)

Tumor recurrence

Yes

8(26.7%)

7(23.3%)

0

No

22(73.3%)

23(76.7%)

v